New Risk • Jun 09
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: AU$14.2m (US$9.98m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company. Announcement • May 15
Australian Dairy Nutritionals Limited has completed a Follow-on Equity Offering in the amount of AUD 1.235064 million. Australian Dairy Nutritionals Limited has completed a Follow-on Equity Offering in the amount of AUD 1.235064 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 19,109,443
Price\Range: AUD 0.028
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 25,000,000
Price\Range: AUD 0.028
Transaction Features: Rights Offering New Risk • Mar 17
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (AU$22.1m market cap, or US$15.7m). Reported Earnings • Mar 02
First half 2026 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in 1H 2025) First half 2026 results: AU$0.002 loss per share (improved from AU$0.003 loss in 1H 2025). Revenue: AU$3.20m (up 14% from 1H 2025). Net loss: AU$1.27m (loss narrowed 38% from 1H 2025). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Announcement • Jan 27
Australian Dairy Nutritionals Limited has filed a Follow-on Equity Offering in the amount of AUD 3.468835 million. Australian Dairy Nutritionals Limited has filed a Follow-on Equity Offering in the amount of AUD 3.468835 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 123,886,970
Price\Range: AUD 0.028
Transaction Features: Rights Offering Announcement • Sep 29
Australian Dairy Nutritionals Limited, Annual General Meeting, Oct 30, 2025 Australian Dairy Nutritionals Limited, Annual General Meeting, Oct 30, 2025. Location: at level 10, tower 4, 727 collins street, docklands vic 3008 Australia Reported Earnings • Aug 31
Full year 2025 earnings released: AU$0.007 loss per share (vs AU$0.011 loss in FY 2024) Full year 2025 results: AU$0.007 loss per share (improved from AU$0.011 loss in FY 2024). Revenue: AU$7.76m (up 24% from FY 2024). Net loss: AU$5.21m (loss narrowed 29% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings. Recent Insider Transactions • Mar 07
Executive Chairman recently bought AU$54k worth of stock On the 4th of March, Peter Nathan bought around 980k shares on-market at roughly AU$0.056 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Peter has been a buyer over the last 12 months, purchasing a net total of AU$225k worth in shares. New Risk • Feb 27
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$4.2m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$4.2m free cash flow). Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 2.9% per year over the past 5 years. Minor Risks Revenue is less than US$5m (AU$5.9m revenue, or US$3.7m). Market cap is less than US$100m (AU$37.9m market cap, or US$23.9m). New Risk • Dec 24
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 6.6% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (13% increase in shares outstanding). Revenue is less than US$5m (AU$6.3m revenue, or US$3.9m). Market cap is less than US$100m (AU$44.6m market cap, or US$27.9m). Recent Insider Transactions • Nov 11
Non-Executive Chairman recently bought AU$51k worth of stock On the 4th of November, Peter Nathan bought around 2m shares on-market at roughly AU$0.021 per share. This transaction amounted to 56% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth AU$81k. Peter has been a buyer over the last 12 months, purchasing a net total of AU$132k worth in shares. Announcement • Oct 28
Australian Dairy Nutritionals Limited, Annual General Meeting, Nov 27, 2024 Australian Dairy Nutritionals Limited, Annual General Meeting, Nov 27, 2024. Location: at moore australia offices, level 44, 600 bourke street, melbourne Australia New Risk • Oct 03
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 13% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 6.6% per year over the past 5 years. Market cap is less than US$10m (AU$14.1m market cap, or US$9.69m). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Shareholders have been diluted in the past year (13% increase in shares outstanding). Revenue is less than US$5m (AU$6.3m revenue, or US$4.3m). Announcement • Oct 03
Australian Dairy Nutritionals Limited Announces Board Changes Australian Dairy Nutritionals Limited announced that Mr. Wenjun (Andy) Zhang has been appointed to the Board as a Non-Executive Director, effective immediately. Andy brings a wealth of experience and knowledge in the Infant Formula category in both China
and Australia with over 10 years experience as a major distributor. Andy has a unique position in the Infant Formula industry in Australia, as he established and built his own cross border business for key ANZ brands from scratch to revenue of circa AUD
400 million empire over a 10 year time-frame. His distribution platform leverages his deep and unique knowledge of e-commerce platforms & the O2O and Daigou channels.Andy holds a master's degree in professional accounting and commerce from Deakin
University. Mr. Zhang is the nominee director of Alpha Professional Holdings Limited. The company also announced the current Non-Executive Chair, Peter Nathan, has accepted the role of Executive Chair, with no additional remuneration. Recent Insider Transactions • Sep 18
Non-Executive Chairman recently bought AU$81k worth of stock On the 16th of September, Peter Nathan bought around 4m shares on-market at roughly AU$0.019 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. This was Peter's only on-market trade for the last 12 months. Announcement • Sep 06
Australian Dairy Nutritionals Limited has filed a Follow-on Equity Offering in the amount of AUD 2.13301 million. Australian Dairy Nutritionals Limited has filed a Follow-on Equity Offering in the amount of AUD 2.13301 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 48,477,509
Price\Range: AUD 0.02
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 48,477,509
Price\Range: AUD 0.024
Transaction Features: Subsequent Direct Listing Reported Earnings • Aug 31
Full year 2024 earnings released: AU$0.011 loss per share (vs AU$0.012 loss in FY 2023) Full year 2024 results: AU$0.011 loss per share. Revenue: AU$6.26m (up 7.0% from FY 2023). Net loss: AU$7.36m (loss widened 7.4% from FY 2023). Announcement • Jun 20
Australian Dairy Nutritionals Limited Announces CEO Changes Australian Dairy Nutritionals Limited announced appointment of Mahinthan Sundaranathan as its new CEO following the resignation of Peter Skene as CEO. On June 17, 2024, Skene had resigned from his position with immediate effect to pursue other interests. Skene, who was with the Victoria-based business for 14 years, will, however, continue to work with the company for up to three months to assist in the transition to a new CEO. Sundaranathan has "over 20 years' experience in the dairy industry across the Australian, Chinese and other Asian markets." He held the role of sales and marketing director and other senior management roles for local peer A2 Milk Company, throughout an eight and a half year tenure with the business. Sundaranathan also worked as a senior brand manager for French dairy giant Danone's Australia business for two and a half years and held various management roles including senior brand manager of fresh dairy for Fonterra's local operation during an 11-year period working with the New Zealand company. Board Change • Apr 21
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Non-Executive Independent Director Jason Dong was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Feb 22
Australian Dairy Nutritionals Limited Announces Management Changes Australian Dairy Nutritionals Limited announced that Elizabeth Spooner has been appointed as Company Secretary, effective 22 February 2024. Peter Skene will resign as Company Secretary, however, will continue to serve as Chief Executive Officer. For the purpose of ASX Listing Rule 12.6, Elizabeth Spooner, Company Secretary, is the person responsible for communications with the ASX in relation to ASX Listing Rule matters. Ms Spooner is a Senior Company Secretary and Corporate Lawyer at Confidant Partners. Ms Spooner holds a Juris Doctor degree from the Australian National University, a Bachelor of Business Administration with Bachelor of Arts (majoring in Human Resources) and a Graduate Diploma of Applied Corporate Governance from the Governance Institute. Announcement • Oct 05
Australian Dairy Nutritionals Limited, Annual General Meeting, Nov 23, 2023 Australian Dairy Nutritionals Limited, Annual General Meeting, Nov 23, 2023. Reported Earnings • Sep 01
Full year 2023 earnings released: AU$0.012 loss per share (vs AU$0.011 loss in FY 2022) Full year 2023 results: AU$0.012 loss per share (further deteriorated from AU$0.011 loss in FY 2022). Revenue: AU$5.86m (down 61% from FY 2022). Net loss: AU$6.85m (loss widened 27% from FY 2022). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings. New Risk • Aug 31
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$7.9m free cash flow). Earnings have declined by 16% per year over the past 5 years. Market cap is less than US$10m (AU$11.1m market cap, or US$7.22m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (19% increase in shares outstanding). Announcement • Aug 09
Australian Dairy Nutritionals Ltd Appoints Qing (Scott) Lai as Director The Board of Australian Dairy Nutritionals Ltd. announced that Mr. Qing (Scott) Lai has been appointed as a director of the Company effective 7 August 2023. Lai brings strong financial market knowledge and an extensive network of more than 1,000 corporate and high net worth investors to the Group. He also has a strong track record of establishing and growing innovative businesses in highly regulated sectors including financial services and energy markets with demonstrated skills managing teams of more than 100 employees. In 2017 Mr. Lai founded IJ Financial Services Pty Ltd. and has grown this business to be a preeminent leader in the fund investment and mortgage loan industry in Queensland with a specific focus on the Chinese market. He spearheads the development, communication and implementation of effective growth strategies to ensure operations are efficient and scalable. He also drives business development initiatives including sourcing and managing new investments and creating opportunities aligned with strategic and financial objectives. Mr. Lai holds a Bachelor of Commerce (Banking, Finance and Risk Management) and a Master of Commerce (Professional Accounting) from Griffith University. He has also been a member of the Financial Education Professionals Pty Ltd. since 2019. Announcement • Jul 28
Australian Dairy Nutritionals Limited Announces Resignation of Adrian Rowley as Director The Board of Australian Dairy Nutritionals Ltd. announced that Mr. Adrian Rowley resigned as a non-executive director of the Company, because ofincreased commitments at his own business. Mr. Rowley has been a director of AHF since 2014, when it first listed on the ASX, and has madea significant contribution during the period of his directorship. Announcement • Jul 13
Australian Dairy Nutritionals Limited has completed a Follow-on Equity Offering in the amount of AUD 1.266667 million. Australian Dairy Nutritionals Limited has completed a Follow-on Equity Offering in the amount of AUD 1.266667 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 33,333,333
Price\Range: AUD 0.03
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 12,121,212
Price\Range: AUD 0.022
Transaction Features: Subsequent Direct Listing Announcement • Jul 12
Australian Dairy Nutritionals Limited has completed a Follow-on Equity Offering in the amount of AUD 0.71 million. Australian Dairy Nutritionals Limited has completed a Follow-on Equity Offering in the amount of AUD 0.71 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 32,272,727
Price\Range: AUD 0.022
Discount Per Security: AUD 0.00132
Transaction Features: Subsequent Direct Listing Announcement • Jun 06
An unknown buyer entered into an agreement to acquire fresh processing assets and lease of the Manifold Street processing site in Camperdown Dairy from Australian Dairy Nutritionals Limited (ASX:AHF) for AUD 1.1 million. An unknown buyer entered into an agreement to acquire fresh processing assets and lease of the Manifold Street processing site in Camperdown Dairy from Australian Dairy Nutritionals Limited (ASX:AHF) for AUD 1.1 million on June 2, 2023. The purchase price is AUD 1.05 million and a deposit of AUD 0.05 million is payable today. If the sale does not proceed because a condition precedent is not satisfied the deposit will be repaid to the buyer. The transaction is subject to certain conditions precedent being satisfied on or before June 21, 2023, including the landlord’s consent to transfer of the lease to the buyer and further due diligence investigations in relation to the trade waste requirements for the buyer’s proposed dairy production. The sale is not conditional on the buyer obtaining finance to fund the purchase price. The transaction is expected to close on June 26, 2023. The proceeds of the sale will be applied towards ADNL’s general working capital requirements. Reported Earnings • Mar 03
First half 2023 earnings released: EPS: AU$0 (vs AU$0.003 loss in 1H 2022) First half 2023 results: EPS: AU$0 (improved from AU$0.003 loss in 1H 2022). Revenue: AU$6.50m (down 25% from 1H 2022). Net income: AU$51.0k (up AU$1.33m from 1H 2022). Profit margin: 0.8% (up from net loss in 1H 2022). Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings. Recent Insider Transactions • Feb 16
Insider recently bought AU$940k worth of stock On the 8th of February, Ding Qiumei bought around 19m shares on-market at roughly AU$0.048 per share. This transaction increased Ding Qiumei's direct individual holding by 2x at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$990k more in shares than they have sold in the last 12 months. Announcement • Feb 11
Australian Dairy Nutritionals Limited Obtains Export Certification The Board of Australian Dairy Nutritionals Group Limited that the Group's infant formula facility located in Camperdown, Victoria has been successful in achieving export certification through the Department of Agriculture, Fisheries and Forestry (DAFF). The export certification means infant formula and other dried milk and milk powder products manufactured at AHF's manufacturing facility can be exported from Australia to international markets, subject to local requirements for importation of these products into each market. All Ocean Road Dairies Organic A2 protein infant formula now produced at the facility will be eligible for export through the Chinese cross-border e-commerce channel (CBEC), and into other key markets, provided the products are registered for import into that market. In the last quarter of 2022, AHF representatives attended two large trade shows in Asia where there was strong interest in the Ocean Road Dairies Organic A2 protein infant formula range so the export certification is a critical step in accessing these markets. Recent Insider Transactions • Dec 22
Independent Chairman of the Group recently bought AU$50k worth of stock On the 19th of December, Martin Bryant bought around 1m shares on-market at roughly AU$0.05 per share. This transaction amounted to 67% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Martin's only on-market trade for the last 12 months. Announcement • Nov 18
Australian Dairy Nutritionals Group Provides Update on US FDA Application The Board of Australian Dairy Nutritionals Group Limited advised that it has received notice from the United States Food and Drug Administration (FDA) that AHF's application for accelerated approval to sell future branded infant formula in the United States has not been accepted. The FDA's temporary approval process was only available for supply until 14th November 2022 however the FDA has encouraged the Group to apply for registration of its future branded infant formula range through the normal registration process. Additionally, the company advanced in preparing toddler milk (stage 3) for launch in the United States next year. Announcement • Oct 05
Australian Dairy Nutritionals Group, Annual General Meeting, Nov 24, 2022 Australian Dairy Nutritionals Group, Annual General Meeting, Nov 24, 2022. Reported Earnings • Sep 06
Full year 2022 earnings released: AU$0.011 loss per share (vs AU$0.015 loss in FY 2021) Full year 2022 results: AU$0.011 loss per share (improved from AU$0.015 loss in FY 2021). Revenue: AU$15.1m (down 31% from FY 2021). Net loss: AU$5.39m (loss narrowed 16% from FY 2021). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings. Announcement • Jul 28
Australian Dairy Nutritionals Group Achieves Another Significant Milestone with the Successful Production of Stage 3 of the Ocean Road Dairies Organic A2 Infant Formula Australian Dairy Nutritionals Group announced that the Group has achieved another significant milestone with the successful production of Stage 3 of the Ocean Road Dairies organic A2 infant formula. This is a critical milestone for the Group's infant formula project and reinforces the Board's confidence that commercial production of the organic A2 infant formula range will occur this quarter, ready for ranging in Chemist Warehouse stores nationally from October 2022. This milestone follows Market Update dated 1 July 2022 advising that the Group had successfully produced Australia's first organic A2 whole milk powder using organic A2 protein milk from farms. Test results for the organic A2 whole milk powder are all within specification enabling it to be used in the ongoing trials of organic A2 infant formula products. The Board is impressed with the progress which the Group has made in bringing this project very close to completion just 24 months after construction commenced on the new infant formula building in June 2020. This is despite the entire project being undertaken under the shadow of Victoria's COVID-19 lockdowns where restrictions on movements of consultants and advisors, personnel absences and logistics delays (particularly for new and replacement parts) have imposed significant challenges. Step Up in Organic Milk Prices; The Board is also pleased to advise that it has already been notified of a step up in the farmgate price of organic milk for FY23. As previously noted, the price difference between conventional and organic milk for the FY23 contracting period was relatively narrow prompting many farmers to cease organic milk production. As a result, availability of organic milk has reduced significantly prompting the Group's processer to offer a step up in the organic milk price less than 4 weeks after FY23 price negotiations have concluded. The step up is expected to deliver approximately $750,000 additional revenue for the Group, assuming FY23 milk production of 500,000 kg of milk solids and, after taking into account the impact that the higher organic milk price will have on the Group's manufacturing segment (where raw milk is a production input). FDA Approval Process for future infant formula range; The Group is also continuing to progress its application with the US Food and Drug Administration (FDA) for accelerated approval for the sale of its future Gradulac Gentle infant formula range in the United States. The application remains under active review. Technical information in relation to the products has been reviewed and the Group has provided the FDA information in relation to its existing inventory and future production capacity. While there are no guarantees, the board and management remain hopeful this progression will result in approval. Announcement • Jul 05
Australian Dairy Receives Requisition Notice from We Say Go On July 5, 2022, The Board of Australian Dairy Nutritionals Group announced that it has received a requisition notice from We Say Go Pty Ltd, Corporate Solutions Pty Ltd, My Superannuation Pty Ltd, Costine Pty Ltd, Fiduciary Nominees Pty Ltd (Convening Securityholders) which advised its intention to call and arrange to hold a general meeting to move resolutions for the removal of: Adrian Rowley and Martin Bryant as directors; and any other director appointed by the Group between the date of the Notice (1 July 2022) and the date of the general meeting. Announcement • Jun 21
Australian Dairy Nutritionals Group and Australian Dairy Farms Trust Announces Board Changes The Board of Australian Dairy Nutritionals Ltd. (Company) and the Australian Dairy Farms Trust (Trust) advised important changes to the composition of the Board of the Company and the Trust. Some time ago, the Group's Chief Executive Officer (CEO), Mr. Peter Skene, expressed his desire to step down from the Board to allow him to focus more fully on the CEO role. At the Board level, Peter Skene contributes significant dairy and food industry knowledge and experience, which the Board recognised would need to be replaced to enable Mr. Skene to step off the Board. The Board advised that it has appointed Mr. Bernard Kavanagh as an independent director to the Board to replace Peter Skene, who has resigned from the Board effective June 21, 2022. Mr. Bernard Kavanagh brings a wealth of dairy and agricultural industry experience as well as both executive and non-executive director experience over many years. Until 2016 he was a senior executive with Saputo Inc., a top 10 global dairy company holding the positions of Vice-President Dairy Divisions International and General Manager Corporate Development. Prior to this he held several senior executive positions over 30 years at Warrnambool Cheese and Butter Co Ltd. including Chief Financial Officer, Company Secretary, General Manager Strategy & Growth and Executive Director. In these roles he led a number of international transactions including mergers and acquisitions, joint ventures, strategic global supply arrangements and major business development projects. He also worked across various international markets including USA, Canada, Japan, China, Europe and Southeast Asia. He has significant listed company Executive and Board experience including capital raising as well as strategy development and oversight. More recently, he held the position of Chairman of Keytone Dairy Corporation Ltd. leading this business through an oversubscribed initial public offering on the Australian Securities Exchange in 2018. Mr. Kavanagh holds a Bachelor of Commerce from Deakin University and is a Fellow of the Institute of Company Secretaries and Administrators as well as a Fellow of the Australian Institute of Company Directors. Announcement • May 31
Australian Dairy Nutritionals Group Confirms Application for FDA Approval The Board of Australian Dairy Nutritionals announced that management has been working closely with Australian and US authorities to progress supply opportunities into the US market and have applied to the US Food & Drug Administration (FDA) for an enforcement discretion to facilitate accelerated approval for its future Gradulac Gentle infant formula range. The Group currently has inventory available as well as inventory scheduled for production in June 2022. Reported Earnings • Sep 03
Full year 2021 earnings released The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2021 results: Revenue: AU$23.5m (up 4.7% from FY 2020). Net loss: AU$6.40m (loss narrowed 14% from FY 2020). Announcement • Aug 24
An unknown buyer entered into a contract to acquire Ecklin South Farm, Victoria from Australian Dairy Nutritionals Group (ASX:AHF) for AUD 5.6 million. An unknown buyer entered into a contract to acquire Ecklin South Farm, Victoria from Australian Dairy Nutritionals Group (ASX:AHF) for AUD 5.6 million on August 24, 2021. A deposit of $0.25 million was paid on execution of the purchase agreement. The proceeds of the farm sale will be used to repay the Australian Dairy Nutritionals Group (ASX:AHF) finance facility in its entirety. The deal is expected to close on 30 September 2021. Executive Departure • Apr 29
Non Executive Director has left the company On the 16th of April, Paul Morrell's tenure as Non Executive Director ended after 3.1 years in the role. As of December 2020, Paul personally held only 250.00k shares (AU$15k worth at the time). A total of 2 executives have left over the last 12 months. Executive Departure • Mar 25
Non-Executive Director has left the company On the 22nd of March, Michael Hackett's tenure as Non-Executive Director ended after 11.9 years in the role. As of December 2020, Michael personally held 3.51m shares (AU$211k worth at the time). Michael is the only executive to leave the company over the last 12 months. Announcement • Feb 26
Australian Dairy Nutritionals Group has completed a Follow-on Equity Offering in the amount of AUD 6.5 million. Australian Dairy Nutritionals Group has completed a Follow-on Equity Offering in the amount of AUD 6.5 million.
Security Name: Stapled Securities
Security Type: Common Stock
Securities Offered: 108,333,334
Price\Range: AUD 0.06
Discount Per Security: AUD 0.0036
Transaction Features: Subsequent Direct Listing Announcement • Feb 16
Australian Dairy Nutritionals Group has completed a Follow-on Equity Offering in the amount of AUD 1.0023 million. Australian Dairy Nutritionals Group has completed a Follow-on Equity Offering in the amount of AUD 1.0023 million.
Security Name: Stapled Securities
Security Type: Common Stock
Securities Offered: 16,704,995
Price\Range: AUD 0.06 Announcement • Feb 12
An unknown buyer completed the acquisition of Drumborg Farm from Australian Dairy Nutritionals Group (ASX:AHF) for AUD 7.4 million. An unknown buyer entered into contract to acquire Drumborg Farm from Australian Dairy Nutritionals Group (ASX:AHF) for AUD 6 million on October 29, 2020. Buyer is required to pay a 10% deposit, AUD 0.06 million payable on execution of the sale contract and the balance when the contract becomes unconditional. The sale contract is conditional on the purchaser obtaining finance to fund the purchase, which must be obtained within 28 days from the date of execution of the sale contract. Provided the purchaser successfully obtains funding for the purchase. As November 30, 2020, an unknown buyer has obtained finance and paid AUD 0.54 million. The settlement of the sale is due to occur on January 29, 2021. As of February 1, 2021, the settlement of the transaction was delayed and is expected to complete this week. As of February 08, 2021, the settlement of the transaction was delayed as the purchaser awaits approval of a final administrative and the board is confident that deal will be closed soon. The sale proceeds will be used to strengthen the balance sheet by repaying part of the Group’s debt facility.
An unknown buyer completed the acquisition of Drumborg Farm from Australian Dairy Nutritionals Group (ASX:AHF) for AUD 7.4 million on February 10, 2021. The proceeds of the sale were used to strengthen Australian Dairy Nutritionals’s balance sheet by repaying AUD 6.15 million to Commonwealth Bank of Australia to reduce the Australian Dairy Nutritionals’s finance facility. The remaining proceeds of the sale (AUD 1.28 million) for livestock and associated items were retained for working capital purposes. Announcement • Dec 15
Australian Dairy Nutritionals Group announced that it expects to receive AUD 6.5 million in funding Australian Dairy Nutritionals Group (ASX:AHF) announced a private placement of 108,333,334 stapled securities at a price of AUD 0.06 per security for gross proceeds of AUD 6,500,000 on December 15, 2020. The transaction will include participation from new and existing institutional, sophisticated and professional investors. The company will receive funding two tranches first tranche of 55,272,898 securities to be received on December 22, 2020 and second tranche of 53,060,436 securities to be received upon approval of shareholders of the company. Announcement • Oct 29
An unknown buyer entered into contract to acquire Drumborg Farm from Australian Dairy Nutritionals Group (ASX:AHF) for AUD 6 million. An unknown buyer entered into contract to acquire Drumborg Farm from Australian Dairy Nutritionals Group (ASX:AHF) for AUD 6 million on October 29, 2020. Buyer is required to pay a 10% deposit, AUD 0.06 million payable on execution of the sale contract and the balance when the contract becomes unconditional. The sale contract is conditional on the purchaser obtaining finance to fund the purchase, which must be obtained within 28 days from the date of execution of the sale contract. Provided the purchaser successfully obtains funding for the purchase, settlement of the sale is due to occur on January 29, 2021. The sale proceeds will be used to strengthen the balance sheet by repaying part of the Group’s debt facility. Announcement • Aug 28
Australian Dairy Nutritionals Group to Report Fiscal Year 2020 Results on Aug 31, 2020 Australian Dairy Nutritionals Group announced that they will report fiscal year 2020 results at 6:05 AM, GMT Standard Time on Aug 31, 2020 Announcement • Jun 20
Australian Dairy Nutritionals Group Not in A Position to Provide Guidance for the Fiscal Year 2020 The Board of Australian Dairy Nutritionals Group announced that it is in the process of assessing the full year financial performance of the Group and is not in a position to provide guidance at this stage as it is assessing the impact of several non- recurring items. In addition, as part of the annual audit process the Group will assess asset valuations in light of current carrying values including the farm portfolio, cattle and Camperdown Dairy Company. 
